CiteFacts · FDA Drug Shortages · FDA source
Triamcinolone Acetonide Injection
Status
FDA source rows are resolved or no longer current.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Harrow Eye, LLC | Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01) | Not stated | 07/31/2026 |
Source facts
Grouped generic ingredient: Triamcinolone Acetonide Injection · 1 package records · Latest FDA row update: 07/31/2026
Therapeutic categories: Ophthalmology
Dosage forms: Injection
Routes: OPHTHALMIC
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.